Health activists from across the country have asked the Union Health and Family Welfare Ministry to take immediate cognisance of the recent report of the Department Related Standing Committee that has criticised the functioning of the Central Drugs Standard Control Organisation (CDSCO) for irregular approvals for clinical trials and sale of medicines to pharmaceutical companies that put patients at risk. In a statement issued here on Wednesday, the activists asked the...
More »SEARCH RESULT
Total Matching Records found : 501
Protests in US over high pricing of Novartis' anti-cancer drug Glivec-Divya Rajagopal
Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous, multi-billion dollar anti-cancer drug Glivec, a development which challenges pharma MNCs' claims of cheap access and affordability for patented drugs. Such protests, which began first in Europe, and have now spread to the US, could make it more difficult for pharma MNCs in developing countries to convince sceptical governments...
More »Indians popping more antibiotics than ever: Study-Kounteya Sinha
There has been a six-fold increase in the number of antibiotics being popped by Indians. This includes the retail sale of Carbapenems -- powerful class IV antibiotics, typically used as a "last resort" to treat serious infections caused by multi-drug resistant, gram-negative pathogens. Research by the Centre for Disease Dynamics, Economics and Policy, Washington DC, has found that retail sale of carbapenems increased six times -- from 0.21 units per million...
More »1,333 doctors migrated abroad last year-Kounteya Sinha
While India faces an acute shortage of trained medical manpower, as many as 1,333 doctors migrated to foreign shores over the last one year. During the same period, the previous year - from April 1, 2010 to March 31, 2011 - 1,157 doctors had migrated in search of employment, and between 2009 and 2010, 1,458 doctors went abroad. This latest revelation by Union health minister Ghulam Nabi Azad on Friday comes just...
More »The government needs to think out of the box to help pharma grow while keeping medicines affordable-Ramesh Adige
Having watched from the ringside for many years now, I have no doubt in advising that the steering wheel must be firmly grasped by the government and direction given to policies that should be stable for at least the medium term. This is crucial for the growth of Indian Pharma, a $20-billion industry growing at an average of 12% considering both domestic and export arenas. Price control: The biggest and most...
More »
